Market Overview:
Anal fissure is a small tear in the anus lining. It commonly causes pain and bleeding during and after a bowel movement. Anal fissure treatment focuses on relieving pain and promoting healing of the tear. Commonly used anal fissure treatment methods include topical medications such as diltiazem or nitrate creams applied to the anal area. Surgery for fissurectomy is considered for cases that do not respond to conservative treatment.
Market Dynamics:
Rise in awareness about advance treatments: Growing awareness about anal fissure treatment options such as lateral internal sphincterotomy and topical nitrate creams is driving the market growth. Key opinion leaders play a crucial role in educating patients about new treatment methods available in the market.
Increasing availability of minimally invasive procedures: Adoption of minimally invasive surgical procedures such as advancement flap repair and advancement flap anoplasty for treating chronic anal fissures is increasing. These procedures help in healing of anal fissures effectively with minimal postoperative pain and quick recovery, thereby boosting the anal fissure treatment market growth over the forecast period.
The global Anal Fissure Treatment Market Size is estimated to be valued at US$ 1,039.3 Mn in 2023 and is expected to exhibit a CAGR of 5.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Segment Analysis
The anal fissure treatment market is dominated bytopical drugs segment owing to its minimally invasive nature and efficacy in promoting wound healing. Topical drugs including nitrates, calcium channel blockers and other local anesthetics help relieve pain and aid in wound healing by increasing blood flow to the affected area.
PEST Analysis
Political: Government regulations around drug approvals determine major revenue sources for manufacturers. Favorable regulations boost revenue streams.
Economic:Growing geriatric population, rising healthcare expenditures and demand for minimally invasive therapiesare major drivers of economic growth in this market.
Social: Increasing awareness about treatmentsfor anal conditionsreducessocial stigmaaroundconsulting doctors, propelling market growth.
Technological:Advancements in development of alternative drug delivery methods like gels and creams have improved patient compliance compared tooral medications.
Key Takeaways
The global Anal Fissure Treatment Market is expected to witness high growth, exhibiting CAGR of 5.3% over the forecast period, due to increasing awareness about treatment options and availability of improved topical drugs.
Regionally, North America dominated the market in 2023 owing tohigher healthcare spending and advanced healthcare facilities in the US and Canada.
Key players operating in the anal fissure treatment market are Allergan, Novartis, Pfizer, Takeda Pharmaceutical Company, Cook Medical, Medtronic, Johnson & Johnson, AstraZeneca, GlaxoSmithKline, Sanofi, Merck, Abbott Laboratories, Bayer, Astellas Pharma, Aurobindo Pharma, Ferring Pharmaceuticals, Salix Pharmaceuticals, Eli Lilly, Bristol-Myers Squibb, Boehringer Ingelheim. Allergan and Novartis hold major market shares due to their diverse product portfolios spanning surgical and topical treatments.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
